Literature DB >> 6773559

Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopencillanic acid: mechanism.

S A Cohen, R F Pratt.   

Abstract

The mechanism of the inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopenicillanic acid, a probable suicide substrate [see Loosemore, M.J., Cohen, S.A., & Pratt, R.F. (1980) Biochemistry (preceding paper in this issue)], is described. Inactivation is accompanied by covalent modification of the protein with the appearance of a characteristic chromophore at 326 nm. Ultraviolet (UV) absorption, nuclear magnetic resonance (NMR), and circular dichroic (CD) spectra of the modified protein, of a modified peptide derived from the protein by enzymatic digestion, and of relevant model compounds suggest that acylation of the enzyme by 6 beta-bromopenicillanic acid is accompanied by rearrangement and cyclization of the inhibitor to a 2,3-dihydro-1,4-thiazine-3,6-dicarboxylic acid derivative, which is the observed chromophore. The acylated residue is shown to be Ser-70. The mechanism of action of beta-lactamase inhibitors is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773559     DOI: 10.1021/bi00558a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.

Authors:  A K Knap; R F Pratt
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

2.  Active-site serine mutants of the Streptomyces albus G beta-lactamase.

Authors:  F Jacob; B Joris; J M Frère
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

3.  6-beta-Iodopenicillanate as a probe for the classification of beta-lactamases.

Authors:  F De Meester; J M Frère; S G Waley; S J Cartwright; R Virden; F Lindberg
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

4.  Evidence for an oxyanion hole in serine beta-lactamases and DD-peptidases.

Authors:  B P Murphy; R F Pratt
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

5.  Trapping the acyl-enzyme intermediate in beta-lactamase I catalysis.

Authors:  S J Cartwright; A K Tan; A L Fink
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

6.  Accumulation of acyl-enzyme intermediates during turnover of penicillins by the class A beta-lactamase of Staphylococcus aureus PC1.

Authors:  R F Pratt; T S McConnell; S J Murphy
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

7.  [Clinical significance of beta-lactamase inhibitors].

Authors:  D Adam
Journal:  Klin Wochenschr       Date:  1988-01-15

8.  Single-turnover and steady-state kinetics of hydrolysis of cephalosporins by beta-lactamase I from Bacillus cereus.

Authors:  R Bicknell; S G Waley
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

9.  beta-Lactamase-catalyzed hydrolysis of acyclic depsipeptides and acyl transfer to specific amino acid acceptors.

Authors:  R F Pratt; C P Govardhan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Interaction of beta-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.

Authors:  J M Frère; C Dormans; C Duyckaerts; J De Graeve
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.